| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Total other income (expense), net | -1,178 | 2,065 | -13,651 | 2,153 |
| Net loss from continuing operations | - | - | -28,866 | -11,203 |
| Net loss | -18,126 | -14,733 | -28,866 | -11,203 |
| Comprehensive loss | - | - | -28,866 | -11,203 |
| Net loss per share, basic (in dollars per share) | -0.69 | -0.56 | -6.31 | -2.45 |
| Net loss per share, diluted (in dollars per share) | -0.69 | -0.56 | -6.31 | -2.45 |
| Weighted-average number of shares used in computing net loss per share, basic (in shares) | 26,228,274 | 26,081,273 | 4,577,122 | 4,572,010 |
| Weighted-average number of shares used in computing net loss per share, diluted (in shares) | 26,228,274 | 26,081,273 | 4,577,122 | 4,572,010 |
Senti Biosciences, Inc. (SNTI)
Senti Biosciences, Inc. (SNTI)